Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Alkermes says Johnson & Johnson ended development of monthly Risperdal Consta injection
Alkermes says Johnson & Johnson ended development of monthly Risperdal Consta injection
Alkermes says Johnson & Johnson ended development of monthly Risperdal Consta injection
Submitted by
admin
on August 27, 2009 - 8:16am
Source:
Yahoo/AP
News Tags:
Alkermes
JNJ
Risperdal Consta
antipsychotics
Headline:
Alkermes says Johnson & Johnson ended development of monthly Risperdal Consta injection
Do Not Allow Advertisers to Use My Personal information
